Are people with lower grade NETs (i.e. Grade 1 Stage 1, receiving only surveillance) less likely to be vulnerable than those with higher grade/stage NETs.


The specific risks are unknown. However, patients on surveillance and with a remote history of surgery are not likely to be immunocompromised, therefore would have an average risk of contracting COVID-19. If you are in surveillance for your NET (getting routine CT or MRI), please ask your oncologist if you can delay the visit, or have a video or telephone visit. Patients on active chemotherapy may have an increased risk of immunocompromise, and therefore a greater risk of contracting COVID-19 or and/or more serious complications.

Posted 2 years agoby globeseek